When combined with intensive behavioral therapy, semaglutide produced significantly greater weight loss than behavior change alone, demonstrating that medication enhances rather than replaces lifestyle modification
References [1] National Library of Medicine, Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts, Chang, C., Tsai, W, Hsu, Y, Pang, J.S., 2014 [2] National Library of Medicine, Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review, Vasireddi, N., Hahamyan, H., Salata, M., Karns, M., Calcei, J., Voos, J., Apostolakos, J., July 2025 [3] National Library of Medicine, Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts, Chang, C., Tsai, W., Hsu, Y., Pang, JS., November 2014
Bio-preservatives also affect the structure and function of cell membranes of spoilage bacteria, increasing membrane permeability and thus compromising the integrity and functionality of bacterial cells
Semaglutide has been shown to aid in weight loss, making it a dual-purpose treatment for those dealing with both diabetes and obesity
